Monsanto, Bayer, Novozymes and Syngenta-backed agricultural technology developer AgBiome increased its overall funding to $230m in the round.
AgBiome, a US-based agricultural technology developer backed by corporates Monsanto, Bayer, Novozymes and Syngenta, collected $116m in series D funding yesterday.
The round was co-led by venture capital firm Novalis LifeSciences and investment firm Blue Horizon while undisclosed new and existing investors also contributed to the financing.
AgBiome has developed the Genesis platform, which is able to identify the gene sequences and strains of microbial life that could potentially protect agricultural crops from pests and disease.
The company has also…
